Ekso Bionics Statistics
Share Statistics
Ekso Bionics has 22.00M shares outstanding. The number of shares has increased by 22.87% in one year.
| Shares Outstanding | 22.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.11% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.72M |
| Failed to Deliver (FTD) Shares | 1.16K |
| FTD / Avg. Volume | 0.98% |
Short Selling Information
The latest short interest is 124.63K, so 0.57% of the outstanding shares have been sold short.
| Short Interest | 124.63K |
| Short % of Shares Out | 0.57% |
| Short % of Float | 0.6% |
| Short Ratio (days to cover) | 1.07 |
Valuation Ratios
The PE ratio is -2.28 and the forward PE ratio is -4.05.
| PE Ratio | -2.28 |
| Forward PE | -4.05 |
| PS Ratio | 1.9 |
| Forward PS | 0.5 |
| PB Ratio | 2.75 |
| P/FCF Ratio | -2.84 |
| PEG Ratio | n/a |
Enterprise Valuation
Ekso Bionics Inc. has an Enterprise Value (EV) of 41.84M.
| EV / Earnings | -2.75 |
| EV / Sales | 2.29 |
| EV / EBITDA | -3.17 |
| EV / EBIT | -2.77 |
| EV / FCF | -3.43 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.48.
| Current Ratio | 2.49 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.48 |
| Total Debt / Capitalization | 32.54 |
| Cash Flow / Debt | -1.98 |
| Interest Coverage | -50.04 |
Financial Efficiency
Return on equity (ROE) is -1.21% and return on capital (ROIC) is -76.42%.
| Return on Equity (ROE) | -1.21% |
| Return on Assets (ROA) | -0.53% |
| Return on Capital (ROIC) | -76.42% |
| Revenue Per Employee | 261.13K |
| Profits Per Employee | -217.11K |
| Employee Count | 70 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -71.76% in the last 52 weeks. The beta is 1.48, so Ekso Bionics 's price volatility has been higher than the market average.
| Beta | 1.48 |
| 52-Week Price Change | -71.76% |
| 50-Day Moving Average | 0.74 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 56.83 |
| Average Volume (20 Days) | 117.91K |
Income Statement
In the last 12 months, Ekso Bionics had revenue of 18.28M and earned -15.20M in profits. Earnings per share was -1.1.
| Revenue | 18.28M |
| Gross Profit | 9.08M |
| Operating Income | -15.11M |
| Net Income | -15.20M |
| EBITDA | -13.20M |
| EBIT | -15.11M |
| Earnings Per Share (EPS) | -1.1 |
Balance Sheet
The company has 8.64M in cash and 7.17M in debt, giving a net cash position of 1.47M.
| Cash & Cash Equivalents | 8.64M |
| Total Debt | 7.17M |
| Net Cash | 1.47M |
| Retained Earnings | -239.15M |
| Total Assets | 29.21M |
| Working Capital | 13.56M |
Cash Flow
In the last 12 months, operating cash flow was -12.05M and capital expenditures -157.00K, giving a free cash flow of -12.21M.
| Operating Cash Flow | -12.05M |
| Capital Expenditures | -157.00K |
| Free Cash Flow | -12.21M |
| FCF Per Share | -0.88 |
Margins
Gross margin is 4.97K%, with operating and profit margins of -8.27K% and -8.31K%.
| Gross Margin | 4.97K% |
| Operating Margin | -8.27K% |
| Pretax Margin | -8.31K% |
| Profit Margin | -8.31K% |
| EBITDA Margin | -72.2% |
| EBIT Margin | -82.67% |
| FCF Margin | -66.8% |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -148.65% |
| FCF Yield | -75.01% |
Analyst Forecast
The average price target for EKSO is $5.5, which is 643.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.5 |
| Price Target Difference | 643.2% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Mar 25, 2020. It was a backward split with a ratio of 1:15.
| Last Split Date | Mar 25, 2020 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -11.34 |
| Piotroski F-Score | 4 |